What is Magnesium Caprate?
Magnesium caprate (CAS Number: 42966-30-3) is an organic salt created by combining magnesium with capric acid (decanoic acid), a saturated fatty acid with ten carbon atoms. This compound belongs to the class of magnesium salts of fatty acids and exists as a white to off-white powder at room temperature. The chemical formula is C20H38MgO4, representing two caprate molecules bonded to one magnesium ion.
Common Uses
Magnesium caprate serves multiple functional roles in food manufacturing:
**Anticaking and Free-Flow Agent**: In powdered and granulated products such as spice blends, salt, baking mixes, and instant beverages, magnesium caprate prevents clumping and moisture absorption, maintaining product flowability and ease of use.
**Emulsifier**: The compound helps stabilize emulsions by promoting the mixing of oil and water-based ingredients in products where separation would otherwise occur, such as certain baked goods, dressings, and processed foods.
**Lubricant and Release Agent**: In tablet and capsule manufacturing, magnesium caprate facilitates the release of products from molds and dies during production, reducing processing difficulties.
The typical use level ranges from 0.5% to 2% by weight, depending on the specific food application and desired functional outcome.
Safety Assessment
Magnesium caprate has not been formally evaluated and approved as a Generally Recognized as Safe (GRAS) additive by the FDA. However, this designation does not indicate that the compound is unsafe; rather, it reflects that manufacturers have not submitted formal GRAS notifications or petitions for this particular ingredient.
Both magnesium and capric acid are recognized food components with established safety histories. Magnesium is an essential mineral found naturally in many foods and is used in numerous approved food additives. Capric acid is a naturally occurring medium-chain fatty acid present in coconut oil, palm oil, and dairy products. The combination of these two well-known food components suggests a relatively low concern profile.
The FDA database shows zero adverse events and zero recalls associated with magnesium caprate, indicating no documented safety incidents or contamination issues in the U.S. food supply. This absence of reported problems, combined with the safe status of its constituent components, provides additional reassurance.
Absorption and metabolism in the human body would likely follow pathways similar to other magnesium salts and medium-chain fatty acids, with minimal systemic accumulation expected. The compound would be expected to have low bioavailability when used at typical food additive levels.
Regulatory Status
Magnesium caprate's regulatory status varies globally:
**United States**: Not listed as GRAS by the FDA. However, it may be used under the Food Additive Amendment provisions if the manufacturer has submitted appropriate safety data to the FDA.
**European Union**: Not listed in the EU's approved food additives database (E-numbers). Food manufacturers in Europe cannot use this additive without prior regulatory approval.
**Other Regions**: Approval status varies by country. Some nations may permit it under their food additive regulations, while others may require specific authorization.
Manufacturers seeking to use magnesium caprate in regulated markets must verify compliance with local regulations and may need to petition regulatory authorities in certain jurisdictions for approval.
Key Studies
Limited peer-reviewed literature specifically addresses magnesium caprate as a food additive. Most relevant research involves:
- General toxicology studies of magnesium salts, which demonstrate safety at typical dietary exposure levels
- Investigations of medium-chain fatty acids and their metabolic fate, showing they are processed similarly to other dietary fats
- Emulsification efficiency studies of fatty acid magnesium salts in various food systems
The lack of extensive specific literature on magnesium caprate likely reflects its limited commercial use rather than safety concerns. Regulatory agencies typically base safety assessments on the known safety of component substances when specific additive data is limited.